One board-ready view of performance, risk and intervention.
This preview shows how Sitora could turn live operating intelligence into a concise monthly board pack. In production, every number would carry source lineage, scope and refresh metadata.
The board discussion should focus on closing the Jeddah operating gap, accelerating accepted-treatment recovery and reducing claims exposure before month end.
Group revenue remains above the prior month, but the variance between best and weakest branches is widening.
Jeddah Tahlia is the main downside risk due to lower chair utilisation, concentrated claims exceptions and a larger accepted-but-unbooked queue.
Riyadh North remains the operating benchmark and provides a transferable workflow for treatment conversion and chair management.
Current interventions have an illustrative modeled monthly upside of SAR 126k if execution assumptions hold.
87% utilisation, 96% governance completeness and the strongest treatment-conversion trend.
Jeddah recovery plan, claims workflow ownership and pilot expansion scope.
Prototype metrics reconcile to synthetic branch totals; production requires source-level validation.